The aim of this observational post market study is to compile real world outcome data on the use of the Conformité Européenne (CE) marked MANTA Vascular Closure Device following percutaneous cardiac or peripheral procedures for large bore (10-18F ID) interventional devices.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time to Hemostasis
Timeframe: Immediately after deployment of MANTA VCD
Number of Participants With One or More Major Access Site Related Complications
Timeframe: within 30 days of procedure